Clinical Trial Update: A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC) [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating postoperative adjuvant chemotherapy with Uracil-Tegafur (UFT) versus surgery alone for gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Uracil-tegafur (UFT) (uracil-tegafur)

Snippet

Sponsor: Taiho Pharmaceutical Co., Ltd. | Conditions: Gastric Cancer | Phase 3 | Status: COMPLETED